Literature DB >> 16452697

Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia.

Mark Olfson1, Steven C Marcus, Joshua Wilk, Joyce C West.   

Abstract

OBJECTIVE: The purpose of this study was to assess the effects of patients' awareness of their illness on the clinical presentation, management, and course of nonadherence to antipsychotic medications among patients with schizophrenia.
METHODS: A national survey was conducted of psychiatrists who were treating patients with schizophrenia. The survey was sent to 771 psychiatrists, of whom 534 responded, for a response rate of 69 percent. The psychiatrists were asked to report on presentation, management, and course for one adult patient with schizophrenia who had been under their care for at least one year and who had been nonadherent to oral antipsychotics at some point in the past year. Patients who were aware that they had a mental illness were compared with those who were not aware.
RESULTS: Of the 534 respondent psychiatrists, 310 reported on an eligible patient, and 300 of these patients were classified by illness awareness. Ninety-seven patients, or 32 percent, were not aware that they had a mental illness. These patients who lacked awareness had significantly longer episodes of antipsychotic nonadherence, were more likely to completely cease taking the antipsychotic medication, were more likely to have severe positive symptoms, and were more likely to be psychiatrically hospitalized after nonadherence than those who were aware of their illness. Psychological interventions and several types of family interventions were significantly less effective among patients who lacked awareness.
CONCLUSIONS: A lack of awareness of mental illness is common among patients with schizophrenia who are nonadherent to antipsychotics. Such nonadherence tends to be especially disruptive and unresponsive to simple commonly used psychological interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452697     DOI: 10.1176/appi.ps.57.2.205

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  28 in total

1.  Suicidal behavior and insight into illness among patients with schizophrenia spectrum disorders.

Authors:  Yu-Chen Kao; Yia-Ping Liu
Journal:  Psychiatr Q       Date:  2011-09

2.  Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics.

Authors:  Christina Mangurian; Aishat Giwa; Erin Brosey; Martha Shumway; James Dilley; Elena Fuentes-Afflick; Eliseo J Pérez-Stable; Dean Schillinger
Journal:  J Am Board Fam Med       Date:  2019 May-Jun       Impact factor: 2.657

3.  Use of depot antipsychotic medications for medication nonadherence in schizophrenia.

Authors:  Joyce C West; Steven C Marcus; Joshua Wilk; Lisa M Countis; Darrel A Regier; Mark Olfson
Journal:  Schizophr Bull       Date:  2007-12-18       Impact factor: 9.306

4.  Antipsychotic treatment patterns and hospitalizations among adults with schizophrenia.

Authors:  Susan dosReis; Elizabeth Johnson; Donald Steinwachs; Charles Rohde; Elizabeth A Skinner; Maureen Fahey; Anthony F Lehman
Journal:  Schizophr Res       Date:  2008-02-05       Impact factor: 4.939

Review 5.  Medication adherence in schizophrenia.

Authors:  Francisco Javier Acosta; José Luis Hernández; José Pereira; Judit Herrera; Carlos J Rodríguez
Journal:  World J Psychiatry       Date:  2012-10-22

6.  Justifying medication decisions in mental health care: Psychiatrists' accounts for treatment recommendations.

Authors:  Beth Angell; Galina B Bolden
Journal:  Soc Sci Med       Date:  2015-04-29       Impact factor: 4.634

7.  Vestibular stimulation improves insight into illness in schizophrenia spectrum disorders.

Authors:  Philip Gerretsen; David D Pothier; Carolyn Falls; Maxine Armstrong; Thushanthi Balakumar; Hiroyuki Uchida; David C Mamo; Bruce G Pollock; Ariel Graff-Guerrero
Journal:  Psychiatry Res       Date:  2017-02-13       Impact factor: 3.222

8.  Toward understanding the insight paradox: internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders.

Authors:  Paul H Lysaker; David Roe; Philip T Yanos
Journal:  Schizophr Bull       Date:  2006-08-07       Impact factor: 9.306

9.  How clients solicit medication changes in psychiatry.

Authors:  Galina B Bolden; Beth Angell; Alexa Hepburn
Journal:  Sociol Health Illn       Date:  2019-01-22

10.  Call it a monster for lack of anything else: narrative insight in psychosis.

Authors:  David Roe; Ilanit Hasson-Ohayon; Shlomo Kravetz; Phil T Yanos; Paul H Lysaker
Journal:  J Nerv Ment Dis       Date:  2008-12       Impact factor: 2.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.